89bio, Inc
$21.119876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$21.11
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.22 (+1.05%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours
Why Robinhood?
You can buy or sell 89bio, Inc and other stocks, options, and ETFs commission-free!
About ETNB
89bio, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases. The company was founded on January 01, 2018 and is headquartered in San Francisco, CA. The listed name for ETNB is 89bio, Inc. Common Stock.
CEO
Rohan Palekar
Employees
20
Headquarters
San Francisco, California
Founded
2018
Market Cap
419.64M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
334.83K
High Today
$21.24
Low Today
$20.73
Open Price
$21.00
Volume
216.98K
52 Week High
$47.25
52 Week Low
$14.00
Collections
Analyst Ratings
100%
of 8 ratings
Buy
100%
Hold
0%
Sell
0%
ETNB Earnings
-$30.63
-$20.42
-$10.21
-$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 17, After Hours